Skip to main content

Table 4 Results of Meta-analysis of medical cost

From: Clinical and economic outcomes of hospital pharmaceutical care: a systematic review and meta-analysis

Study

| SMD

[95% Conf. Interval]

% Weight

Gallagher (2016) [33]

|-2.2e+ 03

−4.7e+ 03

310.072

16.28

Shen (2011) [18]

|-287.300

−439.475

− 135.125

28.23

Gums (1999) [10]

| − 3.1e+ 03

-3.4e+ 03

−2.7e+ 03

27.83

Carter (1997) [8]

|-420.000

− 868.487

28.487

27.66

D + L pooled WMD

|-1.4e+ 03

−3.0e+ 03

155.203

100.00

  1. Heterogeneity chi-squared = 175.82 (d.f. = 3) p = 0.000.
  2. I-squared (variation in WMD attributable to heterogeneity) =98.3%.
  3. Estimate of between-study variance Tau-squared = 2.2e+ 06.
  4. Test of WMD = 0: z = 1.77 p = 0.078.
  5. The significance level of the combined effect quantity test: 0.05.
  6. The significance level of the heterogeneity test: 0.1.
  7. Heterogeneity test: p > 0.1, no heterogeneity was considered; p < 0.1, heterogeneity was considered.